At RGSSH, a three-layer security cover guards the stored vaccine, with about 15 new CCTV cameras recently installed to keep a round-the-clock eye on the facility.
"Each Covaxin vial has 20 doses, and we have received 1,000 vials. Besides, police, paramilitary personnel and our internal security team guard the facility 24x7 in different shifts. These vaccines are worth more than precious gold right now," the official said.
The vaccination rollout will be kicked off from the LNJP Hospital on January 16 with a simple ceremony in the presence of Chief Minister Arvind Kejriwal
and Health Minister Satyendar Jain, sources said on Wednesday.
Meanwhile, the Delhi
Chief Minister's Office tweeted on Wednesday, "Hon'ble CM Shri @ArvindKejriwal will chair a meeting on Thursday, January 14 at 11 AM to review the preparations made under the Delhi
government's Covid vaccination rollout plan".
Also, the sources said, the total number of sites in Delhi
where Covid-19 vaccination rollout will be carried out on January 16 has been revised to 75 from 89 decided earlier by authorities.
A senior official at the hospital said 22 boxes, each containing 1,200 vials of the Oxford Covid-19 vaccine Covishield, were delivered to the facility on Tuesday afternoon. Each vial of 5 milliliters has 10 doses.
The All India Institute of Medical Sciences, Sadarjung Hospital, LNJP Hospital, GTB Hospital, Apollo Hospitals and Max Hospital will be among the vaccination centres here.
India's drugs regulator has approved Oxford Covid-19 vaccine Covishield, manufactured by the Serum Institute, and indigenously developed Covaxin of Bharat Biotech
for restricted emergency use in the country.
Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.
As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.
Support quality journalism and subscribe to Business Standard.